Amgen, AZ Will Pilot FDA's Real-Time Clinical Trial Plan

Amgen, AZ will pilot FDA's real-time clinical trial plan

The FDA has published a plan to allow data from clinical trials to be reported to the agency as they occur in real time.

FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech

Through two pioneering studies, Amgen and AstraZeneca will share study data with FDA scientists as it’s accrued. Elsewhere, Lilly inked a gene editing deal and Pfizer reported success for a multiple myeloma drug.

FDA launches effort to speed up clinical trials, using AI

FDA announces cancer drug trials by AstraZeneca and Amgen will be monitored in real time, a test of how to shorten time interval between trial phases.

FDA is launching real-time monitoring of drug trials, with AstraZeneca and Amgen as first test cases

The agency says 45% of drug development time is currently "dead time" — real-time data access could cut months or years from the process

Amgen, Astra launch real-time trials as part of FDA pilot

Amgen (AMGN) and AstraZeneca (AZN) begin real-time clinical trials as the FDA plans to launch a pilot to accelerate drug development using AI. Read more here.

FDA Announces Major Steps to Implement Real-Time Clinical Trials

White Oak, Md., April 28, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced two major steps as part of an initiative to advance the implementation of real-time clinical trials (RTCT). First, the agency unveiled the successful…